CHEMILOGIC Trademark

Trademark Overview


On Friday, September 2, 2022, a trademark application was filed for CHEMILOGIC with the United States Patent and Trademark Office. The USPTO has given the CHEMILOGIC trademark a serial number of 97576906. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, October 14, 2025. This trademark is owned by Empress Therapeutics, Inc.. The CHEMILOGIC trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical drug development services; scientific research, namely, research and analysis services in the fields of pharmaceuticals and biotechnology for the design and characterization of biologic therapeutic products; pharmaceutical and biotechnology research and development

Pharmaceuticals containing small molecules for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; pharmaceutical preparations and therapeutic agents for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders
chemilogic

General Information


Serial Number97576906
Word MarkCHEMILOGIC
Filing DateFriday, September 2, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, October 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2023

Trademark Statements


Goods and ServicesPharmaceutical drug development services; scientific research, namely, research and analysis services in the fields of pharmaceuticals and biotechnology for the design and characterization of biologic therapeutic products; pharmaceutical and biotechnology research and development
Goods and ServicesPharmaceuticals containing small molecules for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; pharmaceutical preparations and therapeutic agents for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 21, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 19, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEmpress Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
US

Party NameEmpress Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
US

Trademark Events


Event DateEvent Description
Wednesday, September 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 20, 2023ASSIGNED TO EXAMINER
Wednesday, June 21, 2023NON-FINAL ACTION WRITTEN
Wednesday, June 21, 2023NON-FINAL ACTION E-MAILED
Wednesday, June 21, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 19, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 2, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 22, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 22, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 11, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 11, 2024SOU EXTENSION 1 FILED
Thursday, April 11, 2024SOU EXTENSION 1 GRANTED
Friday, April 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 17, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 17, 2024SOU EXTENSION 2 FILED
Thursday, October 17, 2024SOU EXTENSION 2 GRANTED
Thursday, October 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 14, 2025ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 14, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED